Literature DB >> 26363053

Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.

Zhenzhen Zhan1, Hao Cao2, Xuefeng Xie3, Linshan Yang2, Peng Zhang4, Yihan Chen5, Huimin Fan2, Zhongmin Liu2, Xingguang Liu6.   

Abstract

The effective recognition of viral infection and subsequent type I IFN production is essential for the host antiviral innate immune responses. The phosphorylation and activation of kinase TANK-binding kinase 1 (TBK1) plays crucial roles in the production of type I IFN mediated by TLR and retinoic acid-inducible gene I-like receptors. Type I IFN expression must be tightly regulated to prevent the development of immunopathological disorders. However, how the activated TBK1 is negatively regulated by phosphatases remains poorly understood. In this study, we identified a previously unknown role of protein phosphatase (PP)4 by acting as a TBK1 phosphatase. PP4 expression was upregulated in macrophages infected with RNA virus, vesicular stomatitis virus, and Sendai virus in vitro and in vivo. Knockdown of PP4C, the catalytic subunit of PP4, significantly increased type I IFN production in macrophages and dentritic cells triggered by TLR3/4 ligands, vesicular stomatitis virus, and Sendai virus, and thus inhibited virus replication. Similar results were also found in peritoneal macrophages with PP4C silencing in vivo and i.p. infection of RNA virus. Accordingly, ectopic expression of PP4C inhibited virus-induced type I IFN production and promoted virus replication. However, overexpression of a phosphatase-dead PP4C mutant abolished the inhibitory effects of wild-type PP4C on type I IFN production. Mechanistically, PP4 directly bound TBK1 upon virus infection, then dephosphorylated TBK1 at Ser(172) and inhibited TBK1 activation, and subsequently restrained IFN regulatory factor 3 activation, resulting in suppressed production of type I IFN and IFN-stimulated genes. Thus, serine/threonine phosphatase PP4 functions as a novel feedback negative regulator of RNA virus-triggered innate immunity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26363053     DOI: 10.4049/jimmunol.1403083

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.

Authors:  Zhiqiang Deng; Junghyun Lim; Qian Wang; Kerry Purtell; Shuai Wu; Gloria M Palomo; Haiyan Tan; Giovanni Manfredi; Yanxiang Zhao; Junmin Peng; Bo Hu; Shi Chen; Zhenyu Yue
Journal:  Autophagy       Date:  2019-07-30       Impact factor: 16.016

2.  Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor.

Authors:  Douglas W Thomson; Daniel Poeckel; Nico Zinn; Christina Rau; Katrin Strohmer; Anne J Wagner; Alan P Graves; Jessica Perrin; Marcus Bantscheff; Birgit Duempelfeld; Viera Kasparcova; Joshi M Ramanjulu; G Scott Pesiridis; Marcel Muelbaier; Giovanna Bergamini
Journal:  ACS Med Chem Lett       Date:  2019-03-11       Impact factor: 4.345

Review 3.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

4.  PLA1A Participates in the Antiviral Innate Immune Response by Facilitating the Recruitment of TANK-Binding Kinase 1 to Mitochondria.

Authors:  Xiaoxiao Gao; Dan Chen; Xue Hu; Yuan Zhou; Yun Wang; Chunchen Wu; Jizheng Chen; Yanyi Wang; Rongjuan Pei; Xinwen Chen
Journal:  J Innate Immun       Date:  2018-07-17       Impact factor: 7.349

5.  PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1.

Authors:  Weiwen Xiang; Qian Zhang; Xia Lin; Shiying Wu; Yao Zhou; Fansen Meng; Yunyun Fan; Tao Shen; Mu Xiao; Zongping Xia; Jian Zou; Xin-Hua Feng; Pinglong Xu
Journal:  Sci Adv       Date:  2016-07-01       Impact factor: 14.136

6.  Intrahepatic Toll-Like Receptor 3 in Chronic HBV Infection Subjects: Asymptomatic Carriers, Active Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma.

Authors:  Jia Wen Yin; Mao Ping Huang; Bei Zhong
Journal:  Hepat Mon       Date:  2016-05-23       Impact factor: 0.660

7.  Protein phosphatase 4 coordinates glial membrane recruitment and phagocytic clearance of degenerating axons in Drosophila.

Authors:  Lilly M Winfree; Sean D Speese; Mary A Logan
Journal:  Cell Death Dis       Date:  2017-02-23       Impact factor: 8.469

8.  Dephosphorylation of cGAS by PPP6C impairs its substrate binding activity and innate antiviral response.

Authors:  Mi Li; Hong-Bing Shu
Journal:  Protein Cell       Date:  2020-05-30       Impact factor: 14.870

9.  All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells.

Authors:  Marco Bolis; Gabriela Paroni; Maddalena Fratelli; Arianna Vallerga; Luca Guarrera; Adriana Zanetti; Mami Kurosaki; Silvio Ken Garattini; Maurizio Gianni'; Monica Lupi; Linda Pattini; Maria Monica Barzago; Mineko Terao; Enrico Garattini
Journal:  Cancers (Basel)       Date:  2020-05-06       Impact factor: 6.639

10.  Kisspeptin/GPR54 signaling restricts antiviral innate immune response through regulating calcineurin phosphatase activity.

Authors:  Hongjun Huang; Qingqing Xiong; Ning Wang; Ruoyu Chen; Hua Ren; Stefan Siwko; Honghui Han; Mingyao Liu; Min Qian; Bing Du
Journal:  Sci Adv       Date:  2018-08-08       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.